Bukwang's Clevudine awarded HITEK 2002 grand prize

Published: 2002-12-17 06:56:00

Updated: 2002-12-17 06:56:00

The Korea Health Industry Development Institute announced it recently selected 10 new technologies involved in R&D news drugs, medical instruments, foods and cosmetics in HITEC 2002 Award aiming at promoting the domestic research activities of strategic industries in the 21st century.

(1) R&D new drugs:

- Grand prize: Clevudine, chronic hepatitis B agent of Bukwang Pharm

- Honor prize ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.